Rabbit Polyclonal BTNL2 antibody. Suitable for WB, IHC-P and reacts with Human, Mouse samples. Cited in 1 publication. Immunogen corresponding to Recombinant Fragment Protein within Human BTNL2 aa 1 to C-terminus.
View Alternative Names
Butyrophilin-like protein 2, BTL-II, BTNL2
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-BTNL2 antibody (AB223053)
Paraffin embedded sections of human testis tissue were stained for BTNL2 with ab223053 at 1/100 dilution in immunohistochemical analysis.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-BTNL2 antibody (AB223053)
Paraffin embedded sections of human pancreas tissue were stained for BTNL2 with ab223053 at 1/100 dilution in immunohistochemical analysis.
- WB
Supplier Data
Western blot - Anti-BTNL2 antibody (AB223053)
All lanes:
Western blot - Anti-BTNL2 antibody (ab223053) at 1/2000 dilution
Lane 1:
HEK-293 (human epithelial cell line from embryonic kidney) whole cell lysate
Lane 2:
K562 (human chronic myelogenous leukemia cell line from bone marrow ) whole cell lysate
Lane 3:
Mouse brain lysate
Secondary
All lanes:
Goat Anti-Rabbit IgG at 1/50000 dilution
Predicted band size: 50 kDa
Observed band size: 51 kDa
false
Reactivity data
Properties and storage information
Form
Purification technique
Purification notes
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
BTNL2 plays a significant role in modulating immune responses. It forms part of a complex with other immune checkpoint molecules providing inhibitory signals to T cells. This interaction helps maintain immune system balance and prevents excessive immune responses. The presence of BTNL2 in epithelial tissues suggests its involvement in mucosal immunity and interaction with the gut's microbiome.
Pathways
BTNL2 directly participates in the immune checkpoint pathway. It negatively regulates the T-cell receptor signaling pathway in concert with proteins such as CTLA-4 and PD-1. These pathways are critical for maintaining immune homeostasis and avoiding autoimmunity by controlling T-cell activity.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
Biomaterials research 29:0244 PubMed40873954
2025
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com